Shares of Novacyt S.A. (LON:NCYT – Get Free Report) rose 5% during trading on Wednesday . The company traded as high as GBX 72.36 ($0.89) and last traded at GBX 71.40 ($0.88). Approximately 137,563 shares changed hands during trading, an increase of 90% from the average daily volume of 72,583 shares. The stock had previously closed at GBX 68 ($0.84).
Novacyt Trading Up 5.0 %
The stock has a market cap of £50.43 million, a PE ratio of -198.33 and a beta of -1.73. The business’s fifty day moving average is GBX 48.89 and its 200 day moving average is GBX 52.78. The company has a quick ratio of 4.46, a current ratio of 5.09 and a debt-to-equity ratio of 0.36.
Novacyt Company Profile
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Recommended Stories
- Five stocks we like better than Novacyt
- What is MarketRank™? How to Use it
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Invest in the FAANG Stocks
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- CD Calculator: Certificate of Deposit Calculator
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.